







































































































































































B） G３４６Aの変異では制限酵素認識部位は変化しないため，変異遺伝子において制限酵素 Pst Iの認識部位ができるよ
うに，図の下線部のミスマッチ部分（gg→ct）をもつミスマッチプライマーを作成した。このプライマーを用いて
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遺伝子診断とその問題点 １６３
DNA diagnosis ; advantages and weak points
Michinori Ito
Department of Pediatrics, The University of Tokushima School of Medicine, Tokushima, Japan
SUMMARY
In recent years, many disease-related genes has been found with the development of
molecular biological technique and molecular genetical analyses in patients with these dis-
eases have been performed in clinical medicine. DNA diagnosis, diagnosis by detection of
the mutation in disease-related genes, has a lot of advantages compared to usual diagnostic
method. However, DNA diagnosis still has several weak points in clinical medicine. The
first weak point is that we can not diagnose the patient as normal even when no mutation is
found by DNA analysis. The second weak point is that functional analysis of the gene prod-
uct, which is hard in clinical medicine, is necessary to confirm the mutation as the patho-
genic mutation when the new mutation is found in the patient. Finally, it is also the prob-
lem that the sufficient supporting system for the patients after DNA diagnosis is not
established in Japan. Then, it is important that not only advantages but also these weak
points are fully considered before DNA diagnosis.
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